Postmenopausal hormone therapy and risk of stroke: Impact of the route of estrogen administration and type of progestogen

Stroke

Volumn 47, Issue 7, 2016, Pages 1734-1741

  Canonico, Marianne ^a   Carcaillon, Laure ^b   Plu Bureau, Geneviève ^c   Oger, Emmanuel ^a   Singh Manoux, Archana ^a   Tubert Bitter, Pascale ^a,d   Elbaz, Alexis ^a   Scarabin, Pierre Yves ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b INSTITUT DE VEILLE SANITAIRE   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d INSTITUT PASTEUR   (France)

Author keywords

epidemiology; hormones; stroke; women

Indexed keywords

ESTROGEN; NANDROLONE DERIVATIVE; PREGNANE DERIVATIVE; PROGESTERONE; GESTAGEN;

ADULT; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG MEGADOSE; DRUG USE; ESTROGEN THERAPY; FEMALE; FOLLOW UP; HOSPITAL PATIENT; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MIDDLE AGED; NATIONAL HEALTH INSURANCE; PATIENT IDENTIFICATION; POSTMENOPAUSE; PRIORITY JOURNAL; ADVERSE EFFECTS; CUTANEOUS DRUG ADMINISTRATION; FRANCE; HORMONE SUBSTITUTION; INCIDENCE; ORAL DRUG ADMINISTRATION; RISK FACTOR; STROKE;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; ESTROGENS; FEMALE; FRANCE; HORMONE REPLACEMENT THERAPY; HUMANS; INCIDENCE; MIDDLE AGED; POSTMENOPAUSE; PROGESTINS; RISK FACTORS; STROKE;

EID: 84973360875     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.116.013052     Document Type: Article

References (33)

1. Nelson HD, Menopause. Lancet 2008 371 760 770. doi: 10.1016/S0140-6736(08)60346-3.
2. Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE, Prentice RL, Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA 2013 310 1353 1368. doi: 10.1001/jama.2013.278040.
3. Utian WH, Archer DF, Bachmann GA, Gallagher C, Grodstein Fn, Heiman JR, North American Menopause Society Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society. Menopause 2008 15 4 pt 1 584 602. doi: 10.1097/gme.0b013e31817b076a.
4. Olié V, Canonico M, Scarabin PY, Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women. Curr Opin Hematol 2010 17 457 463. doi: 10.1097/MOH.0b013e32833c07bc.
5. Canonico M, Hormone therapy and hemostasis among postmenopausal women: A review. Menopause 2014 21 753 762. doi: 10.1097/GME.0000000000000296.
6. Canonico M, Oger E, Plu-Bureau G, Conard J, Meyer G, Lévesque H, Estrogen and Thromboembolism Risk (ESTHER) Study Group Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation 2007 115 840 845. doi: 10.1161/CIRCULATIONAHA.106.642280.
7. Canonico M, Fournier A, Carcaillon L, Olié V, Plu-Bureau G, Oger E, Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study. Arterioscler Thromb Vasc Biol 2010 30 340 345. doi: 10.1161/ATVBAHA.109.196022.
8. Renoux C, Dell'aniello S, Garbe E, Suissa S, Transdermal and oral hormone replacement therapy and the risk of stroke: A nested case-control study. BMJ 2010 340 c2519
9. Moisan F, Spinosi J, Delabre L, Gourlet V, Mazurie JL, Bénatru I, Association of Parkinson's disease and its subtypes with agricultural pesticide exposures in men: A case-control study in France. Environ Health Perspect 2015 123 1123 1129. doi: 10.1289/ehp.1307970.
10. Sare GM, Gray LJ, Bath PM, Association between hormone replacement therapy and subsequent arterial and venous vascular events: A meta-Analysis. Eur Heart J 2008 29 2031 2041. doi: 10.1093/eurheartj/ehn299.
11. Paganini-Hill A, Ross RK, Henderson BE, Postmenopausal oestrogen treatment and stroke: A prospective study. BMJ 1988 297 519 522
12. Petitti DB, Sidney S, Quesenberry CP Jr, Bernstein A, Ischemic stroke and use of estrogen and estrogen/progestogen as hormone replacement therapy. Stroke 1998 29 23 28
13. Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ, A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 2000 133 933 941
14. Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Suissa S, Horwitz RI, A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med 2001 345 1243 1249. doi: 10.1056/NEJMoa010534.
15. Løkkegaard E, Jovanovic Z, Heitmann BL, Keiding N, Ottesen B, Hundrup YA, Increased risk of stroke in hypertensive women using hormone therapy: Analyses based on the Danish Nurse Study. Arch Neurol 2003 60 1379 1384. doi: 10.1001/archneur.60.10.1379.
16. Wassertheil-Smoller S, Hendrix SL, Limacher M, Heiss G, Kooperberg C, Baird A, WHI Investigators Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: A randomized trial. JAMA 2003 289 2673 2684. doi: 10.1001/jama.289.20.2673.
17. Hendrix SL, Wassertheil-Smoller S, Johnson KC, Howard BV, Kooperberg C, Rossouw JE, WHI Investigators Effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation 2006 113 2425 2434. doi: 10.1161/CIRCULATIONAHA.105.594077.
18. Grodstein F, Manson JE, Stampfer MJ, Rexrode K, Postmenopausal hormone therapy and stroke: role of time since menopause and age at initiation of hormone therapy. Arch Intern Med 2008 168 861 866. doi: 10.1001/archinte.168.8.861.
19. Vickers MR, MacLennan AH, Lawton B, Ford D, Martin J, Meredith SK, WISDOM group Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): A randomised controlled trial of hormone replacement therapy in postmenopausal women. BMJ 2007 335 239. doi: 10.1136/bmj.39266.425069.AD.
20. Carcaillon L, Alhenc-Gelas M, Bejot Y, Spaft C, Ducimetière P, Ritchie K, Increased thrombin generation is associated with acute ischemic stroke but not with coronary heart disease in the elderly: the Three-City cohort study. Arterioscler Thromb Vasc Biol 2011 31 1445 1451. doi: 10.1161/ATVBAHA.111.223453.
21. Undas A, Ariëns RA, Fibrin clot structure and function: A role in the pathophysiology of arterial and venous thromboembolic diseases. Arterioscler Thromb Vasc Biol 2011 31 e88 e99. doi: 10.1161/ATVBAHA.111.230631.
22. Rossouw JE, Johnson KC, Pettinger M, Cushman M, Sandset PM, Kuller L, Tissue factor pathway inhibitor, activated protein C resistance, and risk of ischemic stroke due to postmenopausal hormone therapy. Stroke 2012 43 952 957. doi: 10.1161/STROKEAHA.111.643072.
23. Sexton T, Smyth SS, Novel mediators and biomarkers of thrombosis. J Thromb Thrombolysis 2014 37 1 3. doi: 10.1007/s11239-013-1034-5.
24. Scarabin PY, Hemker HC, Clément C, Soisson V, Alhenc-Gelas M, Increased thrombin generation among postmenopausal women using hormone therapy: importance of the route of estrogen administration and progestogens. Menopause 2011 18 873 879. doi: 10.1097/gme.0b013e31820eee88.
25. Canonico M, Alhenc-Gelas M, Plu-Bureau G, Olié V, Scarabin PY, Activated protein C resistance among postmenopausal women using transdermal estrogens: importance of progestogen. Menopause 2010 17 1122 1127. doi: 10.1097/gme.0b013e3181e102eb.
26. Rey RC, de Larrañaga G, Lepera S, Cohen M, Saposnik G, Alonso B, Activated protein C resistance in patients with arterial ischemic stroke. J Stroke Cerebrovasc Dis 2001 10 128 131. doi: 10.1053/jscd.2001.25464.
27. Ciccone MM, Cicinelli E, Giovanni A, Scicchitano P, Gesualdo M, Zito A, Ophthalmic artery vasodilation after intranasal estradiol use in postmenopausal women. J Atheroscler Thromb 2012 19 1061 1065
28. Ciccone MM, Scicchitano P, Gesualdo M, Fornarelli F, Pinto V, Farinola G, Systemic vascular hemodynamic changes due to 17-β-estradiol intranasal administration. J Cardiovasc Pharmacol Ther 2013 18 354 358. doi: 10.1177/1074248413484385.
29. Aboa-Eboulé C, Mengue D, Benzenine E, Hommel M, Giroud M, Béjot Y, How accurate is the reporting of stroke in hospital discharge data? A pilot validation study using a population-based stroke registry as control. J Neurol 2013 260 605 613. doi: 10.1007/s00415-012-6686-0.
30. Moulis G, Lapeyre-Mestre M, Palmaro A, Pugnet G, Montastruc JL, Sailler L, French health insurance databases: What interest for medical research? Rev Med Interne 2015 36 411 417. doi: 10.1016/j.revmed.2014.11.009.
31. Erenus M, Karakoç B, Gürler A, Comparison of effects of continuous combined transdermal with oral estrogen and oral progestogen replacement therapies on serum lipoproteins and compliance. Climacteric 2001 4 228 234
32. Manson JE, Colditz GA, Stampfer MJ, Willett WC, Krolewski AS, Rosner B, A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 1991 151 1141 1147
33. Scarabin-Carré V, Canonico M, Brailly-Tabard S, Trabado S, Ducimetière P, Giroud M, High level of plasma estradiol as a new predictor of ischemic arterial disease in older postmenopausal women: the three-city cohort study. J Am Heart Assoc 2012 1 e001388. doi: 10.1161/JAHA.112.001388.